BioWorld MedTech

Oct. 2, 2014

EuroSpine Week: MIS stalled in spine despite promise versus open procedure

LYON, France — The leading manufacturers of the myriad hardware used for spine surgery cor expanded platforms for minimally invasive surgery (MIS). Read More

Claret trumpets results of CLEAN-TAVI, tackles question 'What now?'

Inside the Belthway: Journal article blasts FDA for lack of data disclosure for 510(k) implants

Alimera details on 'much broader' U.S. opportunity for Iluvien than in Europe

Daily M&A: Owens & Minor acquires Medical Action Industries

World in Review: Vision-Sciences to launch EndoSheath tech in Europe

People in Places

Court: Endo reaches settlements with vaginal mesh products

Hit Bits: Royal Solutions integrates with Merge Healthcare

product briefs

MDD's Ortopedic Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 14, 2025.

European VCs optimistic for med-tech exit opportunities in 2025

BioWorld MedTech

To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for February 14, 2025

European VCs bullish on med-tech investments in 2025

BioWorld MedTech

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...